CME - Neurology: A Primary Care Approach

Venue: Hyatt Sarasota on Sarasota Bay

Location: Sarasota, Florida, United States

Event Date/Time: Feb 11, 2008 End Date/Time: Feb 15, 2008
Early Registration Date: Jan 12, 2008
Report as Spam


SPECIFIC OBJECTIVES - DAY 1 - THE NUTS AND BOLTS OF PERFORMING A NEUROLOGICAL EXAMINATION – Obtain a more precise history of weakness or numbness. Perform a more complete screening neurological examination. When to use supplementary portions of the exam in selected clinical situations. Common pitfalls and errors in performing the neurological examination. INTERPRETING THE NEUROLOGICAL EXAMINATION: A CASE-BASED APPROACH – Common abnormalities on the neurological examination. Determine whether a lesion is in the central or peripheral nervous system. Categorize weakness and numbness by their patterns of distribution and recognize these patterns as aids to localization. Selected cases which will serve as examples of how to recognize and localize classic problems noted on the neurological examination. CRANIAL NEUROPATHIES: VERTIGO, BELL'S PALSY AND TRIGEMINAL NEURALGIA – Clinical features of cranial neuropathies. Techniques available to confirm a diagnosis of cranial neuropathy. Therapeutic modalities available to treat vertigo, Bell’s palsy, and trigeminal neuralgia. VISUAL LOSS AND DOUBLE VISION: NEURO-OPHTHALMOLOGY FOR THE PRIMARY CARE PHYSICIAN – Differential diagnosis for patients presenting with acute and chronic monocular loss of vision. Differential diagnosis for patients presenting with horizontal and vertical diplopia. Components of the bedside neurologic exam which will distinguish between the various etiologies of visual loss and diplopia. Therapeutic and prognostic aspects of the specific causes of visual loss and diplopia. DAY 2 - NEURODIAGNOSTICS TESTS: HOW CAN THEY HELP YOU MAKE THE DIAGNOSIS? – Indications for neurodiagnostic studies and answer the questions: Should every seizure patient have an EEG? Should every numb hand have an EMG? False positives and incidental findings obtained from neurodiagnostic testing. Limitations of EMG, EEG and lumbar puncture. Obtaining useful information from neurodiagnostic tests. Advising patients as to what is involved in the performance of these selective neurodiagnostic tests. NEURORADIOLOGY: INTERPRETING THE INTERPRETATIONS OF CAT SCAN AND MRI – Clinical relevance of the findings reviewed in CAT scan and MRI reports. The rationale for ordering neuroradiologic testing. Common neuroradiologic abnormalities. AN EFFECTIVE APPROACH TO GAIT ABNORMALITIES – Common gait abnormalities, both persistent and episodic. Evaluate patients with gait dysfunction using a directed neurological exam and appropriate lab and imaging studies. Categorize persistent gait abnormalities into dysfunction of sensation, power, balance, coordination/posture, and tone. Hysterical gait abnormalities. THE CLINICIAN’S APPROACH TO PERIPHERAL NEUROPATHY – The multiple presentations of the neuropathy of diabetes. Differential diagnosis of patients who present with peripheral neuropathy. Diagnostic work-up of patients with peripheral neuropathy. Therapeutic options available for peripheral neuropathy. DAY 3 - ALZHEIMER’S DISEASE AND OTHER DEMENTIAS – Evaluate patients with dementia and answer the question: What testing should be done in a patient with suspected Alzheimer’s disease? Answer the question: What are the red flags suggesting that special testing for other causes of dementia is appropriate? When to initiate a Cholinesterase inhibitor or NMDA antagonist in patients with Alzheimer’s disease. What interventions for depression and agitation can be most helpful in their patients with Alzheimer’s disease. ESSENTIAL TREMOR AND PARKINSON’S DISEASE – Mild Parkinson’s disease and other disorders that produce parkinsonism. What medications to begin in their patients with Parkinson’s disease and essential tremor. The intractable patient with Parkinson’s disease or essential tremor and advanced strategies for treatment of these movement disorders including deep brain stimulation. Other types of tremor in addition to those seen in Parkinson’s disease and essential tremor. MULTIPLE SCLEROSIS IN THE 21ST CENTURY – Clinical features of patients with multiple sclerosis. Diagnostic testing strategy to confirm a diagnosis of multiple sclerosis. Etiologic questions in multiple sclerosis. Newest therapeutic advances in the treatment of multiple sclerosis. MIGRAINE AND OTHER HEADACHES: A DIAGNOSTIC APPROACH LEADING TO RATIONAL THERAPY – Clinical spectrum of symptoms in patients with migraine headache. Types of headache which can mimic migraine. Newest therapeutic advances in the treatment of migraine headache. DAY 4 - BRAIN ATTACK! ACUTE TREATMENT OF STROKE AND TIA – Imaging studies of the brain and cerebral vessels in the setting of acute cerebrovascular disease. How management of blood pressure, fever, blood sugar and airway can improve the prognosis of stroke patients. Time is brain and what immediate interventions, including thrombolytics, are necessary in stroke patients. Manage and triage patients with intracerebral hemorrhage. HOW TO MINIMIZE YOUR PATIENT’S RISK OF STROKE – Most recent developments in the use of statins and antihypertensive medications in patients with a risk for stroke. Risk factors for stroke. Selecting an antiplatelet or anticoagulant medication after a stroke or TIA. Indications and potential benefits of vascular procedures such as carotid endarterectomy and stenting. THE DIAGNOSIS AND TREATMENT OF NEUROPATHIC PAIN, PARTS 1 AND 2 – Current thinking about the pathophysiology of neuropathic pain. Clinical features of a patient with neuropathic pain. Pharmacologic options available to treat patients with neuropathic pain. Clinical features which distinguish lumbosacral radiculopathy from other causes of low back pain. Clinical spectrum of lumbosacral radiculopathy. DAY 5 - DIAGNOSIS AND TREATMENT OF EPILEPSY – Differentiate seizures from syncope, pseudoseizures and other masqueraders. Approach to initiating treatment with anticonvulsants. Use of anticonvulsants in pregnancy and in the elderly. When to stop anticonvulsants. In status epilepticus, time is brain - an approach to treatment to stop status epilepticus in 1 ½ hours or less. SYNCOPE: A REVIEW OF FITS, FAINTS, AND FUNNY SPELLS – Neurologic and non-neurologic causes of syncope. Clinical features of dysautonomia, POTS and neurocardiogenic syncope. Role of diagnostic testing in patients presenting with syncope. Therapeutic options available for patients with dysautonomia and neurocardiogenic syncope. TO SLEEP, PERCHANCE TO DREAM: COMMON SLEEP DISORDERS – Obtaining a sleep history. The utility of these studies and answer the question: Should your sleepy patient get a polysomnogram or multiple sleep latency study? Common sleep disorders such as insomnia, obstructive sleep apnea, narcolepsy and restless legs syndrome. MYASTHENIA GRAVIS AND MYOPATHY – Clinical features of myasthenia gravis and other disorders of the neuromuscular junction. Clinical features and differential diagnosis for patients with myopathy. Diagnostic testing available for patients presenting with symptoms of either myasthenia gravis or myopathy. Therapeutic options available for patients with myasthenia gravis and myopathy.


1000 Boulevard of the Arts
United States

Additional Information

Physician Fees $725.00 Regular Registration (30 days prior to seminar start date) $775.00 Late Registration Non Physician/Resident* Fees $625.00 Regular Registration (30 days prior to seminar start date) $675.00 Late Registration